Stimcell Energetics (STME) Enterprise Value (QoQ) (2016 - 2026)
Stimcell Energetics (STME) Enterprise Value (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 77.78% |
| Nov 30, 2025 | -617.09% |
| Aug 31, 2025 | 55.85% |
| May 31, 2025 | -118.34% |
| Feb 28, 2025 | 80.25% |
| Nov 30, 2024 | -64.56% |
| Aug 31, 2024 | 52.66% |
| May 31, 2024 | 45.51% |
| Feb 29, 2024 | -252.19% |
| Nov 30, 2023 | 61.04% |
| Aug 31, 2023 | 40.92% |
| May 31, 2023 | -1,188.61% |
| Feb 28, 2023 | 57.18% |
| Nov 30, 2022 | -85.17% |
| Aug 31, 2022 | 60.54% |
| May 31, 2022 | 20.68% |
| Feb 28, 2022 | 17.26% |
| Nov 30, 2021 | 41.75% |
| Aug 31, 2021 | -207.29% |
| May 31, 2021 | 20.08% |